Appendix JTolerability and overall adverse events of ICSs

Publication Details

Summary table of ICS adverse events and tolerability from head-to-head RCTs.

Table

Summary table of ICS adverse events and tolerability from head-to-head RCTs.

References for Appendix J

1.
Molimard M, Martinat Y, Rogeaux Y, Moyse D, Pello JY, Giraud V. Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. Respir Med. 2005 Jun;99(6):770–778. [PubMed: 15878495]
2.
Tattersfield AE, Town GI, Johnell O, et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax. 2001 Apr;56(4):272–278. [PMC free article: PMC1746016] [PubMed: 11254817]
3.
Worth H, Muir JF, Pieters WR. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration. 2001;68(5):517–526. [PubMed: 11694816]
4.
Chylack LT Jr, Gross GN, Pedinoff A. A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity. J Asthma. 2008 Dec;45(10):893–902. [PubMed: 19085579]
5.
Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J. 1993 Jun;6(6):877–885. [PubMed: 8339809]
6.
Boe J, Bakke P, Rodolen T, Skovlund E, Gulsvik A. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. Eur Respir J. 1994 Dec;7(12):2179–2184. [PubMed: 7713201]
7.
de Benedictis FM, Teper A, Green RJ, Boner AL, Williams L, Medley H. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med. 2001 Nov;155(11):1248–1254. [PubMed: 11695935]
8.
Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax. 1993 Aug;48(8):817–823. [PMC free article: PMC464708] [PubMed: 8211872]
9.
Fairfax A, Hall I, Spelman R. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Ann Allergy Asthma Immunol. 2001 May;86(5):575–582. [PubMed: 11379810]
10.
Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr. Respir Med. 1996 Nov;90(10):609–617. [PubMed: 8959118]
11.
Lundback B, Alexander M, Day J, et al. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler. Respir Med. 1993 Nov;87(8):609–620. [PubMed: 8290745]
12.
Malo JL, Cartier A, Ghezzo H, et al. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone. Eur Respir J. 1999 May;13(5):993–998. [PubMed: 10414395]
13.
Medici TC, Grebski E, Hacki M, Ruegsegger P, Maden C, Efthimiou J. Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects. Thorax. 2000 May;55(5):375–382. [PMC free article: PMC1745755] [PubMed: 10770818]
14.
Raphael GD, Lanier RQ, Baker J, Edwards L, Rickard K, Lincourt WR. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma. J Allergy Clin Immunol. 1999 May;103(5 Pt 1):796–803. [PubMed: 10329812]
15.
Bernstein DI, Berkowitz RB, Chervinsky P, et al. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. Respir Med. 1999 Sep;93(9):603–612. [PubMed: 10542973]
16.
Nathan RA, Nayak AS, Graft DF, et al. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Ann Allergy Asthma Immunol. 2001 Feb;86(2):203–210. [PubMed: 11258691]
17.
Berkowitz R, Rachelefsky G, Harris AG, Chen R. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics. Chest. 1998 Sep;114(3):757–765. [PubMed: 9743163]
18.
Bronsky E, Korenblat P, Harris AG, Chen R. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma. Ann Allergy Asthma Immunol. 1998 Apr;80(4):295–302. [PubMed: 9564977]
19.
Boulet LP, Drollmann A, Magyar P, et al. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. Respir Med. 2006 May;100(5):785–794. [PubMed: 16427266]
20.
Hansel TT, Benezet O, Kafe H, et al. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma. Clin Ther. 2006 Jun;28(6):906–920. [PubMed: 16860173]
21.
Ukena D, Biberger C, Steinijans V, et al. Ciclesonide is more effective than budesonide in the treatment of persistent asthma. Pulm Pharmacol Ther. 2007;20(5):562–570. [PubMed: 16962345]
22.
Vermeulen JH, Gyurkovits K, Rauer H, Engelstatter R. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma. Respir Med. 2007 Oct;101(10):2182–2191. [PubMed: 17614270]
23.
von Berg A, Engelstatter R, Minic P, et al. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma. Pediatr Allergy Immunol. 2007 Aug;18(5):391–400. [PubMed: 17617808]
24.
Newhouse M, Knight A, Wang S, Newman K. Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group. Ann Allergy Asthma Immunol. 2000 Mar;84(3):313–319. [PubMed: 10752915]
25.
Ayres JG, Bateman ED, Lundback B, Harris TA. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J. 1995 Apr;8(4):579–586. [PubMed: 7664857]
26.
Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr. 1999 Apr;134(4):422–427. [PubMed: 10190915]
27.
Heinig JH, Boulet LP, Croonenborghs L, Mollers MJ. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma. Respir Med. 1999 Sep;93(9):613–620. [PubMed: 10542974]
28.
Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg × day(-1) Eur Respir J. 1996 Nov;9(11):2263–2272. [PubMed: 8947070]
29.
Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab. 2000 Feb;85(2):652–657. [PubMed: 10690871]
30.
Ringdal N, Swinburn P, Backman R, et al. A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: A clinical evaluation. Mediators of Inflammation. 1996;5(5):382–389. [PMC free article: PMC2365805] [PubMed: 18475734]
31.
Bousquet J, D’Urzo A, Hebert J, et al. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J. 2000 Nov;16(5):808–816. [PubMed: 11153576]
32.
Corren J, Berkowitz R, Murray JJ, Prenner B. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract. 2003 Sep;57(7):567–572. [PubMed: 14529054]
33.
Weiss KB, Liljas B, Schoenwetter W, Schatz M, Luce BR. Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings. Clin Ther. 2004 Jan;26(1):102–114. [PubMed: 14996523]
34.
Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstatter R. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma. Pulm Pharmacol Ther. 2008;21(2):264–275. [PubMed: 17604664]
35.
Boulet LP, Bateman ED, Voves R, Muller T, Wolf S, Engelstatter R. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. Respir Med. 2007 Aug;101(8):1677–1686. [PubMed: 17448650]
36.
Buhl R, Vinkler I, Magyar P, et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther. 2006;19(6):404–412. [PubMed: 16310388]
37.
Dahl R, Engelstatter R, Trebas-Pietras E, Kuna P. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma. Respiratory Medicine. 2010 Aug;104(8):1121–1130. [PubMed: 20430601]
38.
Knox A, Langan J, Martinot JB, Gruss C, Hafner D. Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma. Curr Med Res Opin. 2007 Oct;23(10):2387–2394. [PubMed: 17714607]
39.
Lipworth BJ, Kaliner MA, LaForce CF, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol. 2005 Apr;94(4):465–472. [PubMed: 15875528]
40.
Magnussen H, Hofman J, Staneta P, Lawo JP, Hellwig M, Engelstatter R. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma. J Asthma. 2007 Sep;44(7):555–563. [PubMed: 17885859]
41.
Pedersen S, Engelstatter R, Weber HJ, et al. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pulm Pharmacol Ther. 2009 Jun;22(3):214–220. [PubMed: 19141327]
42.
Pedersen S, Garcia Garcia ML, Manjra A, Theron I, Engelstatter R. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. Pediatr Pulmonol. 2006 Oct;41(10):954–961. [PubMed: 16868976]
43.
O’Connor B, Bonnaud G, Haahtela T, et al. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol. 2001 Apr;86(4):397–404. [PubMed: 11345282]
44.
Baraniuk J, Murray JJ, Nathan RA, et al. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Chest. 1999 Sep;116(3):625–632. [PubMed: 10492263]
45.
Condemi JJ, Chervinsky P, Goldstein MF, et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol. 1997 Oct;100(4):467–474. [PubMed: 9338539]
46.
Gross GN, Wolfe JD, Noonan MJ, et al. Differential effects of inhaled corticosteroids: Fluticasone propionate versus triamcinolone acetonide. American Journal of Managed Care. 1998;4(2):233–244.